Nicoletta Loggia

Nicoletta Loggia is an accomplished professional with extensive experience in the pharmaceutical and biotechnology fields. Currently serving as a Board Member at Candel Therapeutics and an Advisory Board Member at Sarcura GmbH, Nicoletta also holds the position of Chief Technical Officer at Orchard Therapeutics. Prior to these roles, Nicoletta spent over 17 years at Novartis, where pivotal leadership in cell and gene therapies included positions such as Global Head Cell & Gene Therapies and Global Head Technical Development Biologics & Cell Gene Therapies. Previous experience includes senior scientific roles at Pfizer and healthcare consulting at Datamonitor Healthcare. Nicoletta's educational background includes a Master and PhD in Chemistry & Pharmaceutical Technologies from Università di Pavia and a Diploma in Law and Society from Canterbury Christ Church University. Additional studies are being pursued at EPFL.